Diane L. Parks
CIK: 0001781026
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Oct 12, 2026SNGX
SOLIGENIX, INC.
Disposition(D)DirectStock Option (Right to Buy)
56 shares- - Oct 12, 2026SNGX
SOLIGENIX, INC.
Disposition(D)DirectStock Option (Right to Buy)
121 shares- - Oct 12, 2026SNGX
SOLIGENIX, INC.
Disposition(D)DirectStock Option (Right to Buy)
6 shares- - Oct 12, 2026SNGX
SOLIGENIX, INC.
Disposition(D)DirectStock Option (Right to Buy)
128 shares- - Oct 12, 2026SNGX
SOLIGENIX, INC.
Disposition(D)DirectStock Option (Right to Buy)
63 shares- - Oct 12, 2026SNGX
SOLIGENIX, INC.
Disposition(D)DirectStock Option (Right to Buy)
192 shares- - Sep 17, 2026SNGX
SOLIGENIX, INC.
Award(A)DirectStock Option (Right to Buy)
78.9K shares- - Jun 4, 2026KURA
Kura Oncology, Inc.
Award(A)DirectOption to purchase common stock
35K shares- - Jan 12, 2026CELU
Celularity Inc
Award(A)Direct30K shares- - Dec 29, 2025CELU
Celularity Inc
Award(A)Direct125K shares- - Dec 19, 2025CELU
Celularity Inc
Award(A)Direct67.4K shares- - Nov 19, 2025CELU
Celularity Inc
Award(A)Direct61.5K shares- - Jun 20, 2025SNGX
SOLIGENIX, INC.
Award(A)DirectStock Option (Right to Buy)
17.6K shares- - Jun 5, 2025KURA
Kura Oncology, Inc.
Award(A)DirectOption to purchase common stock
28.5K shares- - Dec 19, 2024CELU
Celularity Inc
Award(A)Direct67.4K shares- - Dec 12, 2024SNGX
SOLIGENIX, INC.
Award(A)DirectStock Option (Right to Buy)
8.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 12, 2026 |  SNGX SOLIGENIX, INC. | Disposition(D) Stock Option (Right to Buy) | 56 | - | - | Direct |
| Oct 12, 2026 | SNGX SOLIGENIX, INC. | Disposition(D) Stock Option (Right to Buy) | 121 | - | - | Direct |
| Oct 12, 2026 | SNGX SOLIGENIX, INC. | Disposition(D) Stock Option (Right to Buy) | 6 | - | - | Direct |
| Oct 12, 2026 | SNGX SOLIGENIX, INC. | Disposition(D) Stock Option (Right to Buy) | 128 | - | - | Direct |
| Oct 12, 2026 | SNGX SOLIGENIX, INC. | Disposition(D) Stock Option (Right to Buy) | 63 | - | - | Direct |
| Oct 12, 2026 | SNGX SOLIGENIX, INC. | Disposition(D) Stock Option (Right to Buy) | 192 | - | - | Direct |
| Sep 17, 2026 | SNGX SOLIGENIX, INC. | Award(A) Stock Option (Right to Buy) | 78,947 | - | - | Direct |
| Jun 4, 2026 |  KURA Kura Oncology, Inc. | Award(A) Option to purchase common stock | 35,000 | - | - | Direct |
| Jan 12, 2026 |  CELU Celularity Inc | Award(A) | 30,000 | - | $0 | Direct |
| Dec 29, 2025 | CELU Celularity Inc | Award(A) | 125,000 | - | - | Direct |
| Dec 19, 2025 | CELU Celularity Inc | Award(A) | 67,416 | - | - | Direct |
| Nov 19, 2025 | CELU Celularity Inc | Award(A) | 61,539 | - | - | Direct |
| Jun 20, 2025 | SNGX SOLIGENIX, INC. | Award(A) Stock Option (Right to Buy) | 17,647 | - | - | Direct |
| Jun 5, 2025 | KURA Kura Oncology, Inc. | Award(A) Option to purchase common stock | 28,500 | - | - | Direct |
| Dec 19, 2024 | CELU Celularity Inc | Award(A) | 67,416 | - | $0 | Direct |
| Dec 12, 2024 | SNGX SOLIGENIX, INC. | Award(A) Stock Option (Right to Buy) | 8,646 | - | - | Direct |
1-16 of 16 transactions
About Parks Diane L.
Parks Diane L. (SEC CIK 0001781026) files insider reports with the SEC as Director of SOLIGENIX, INC. (SNGX), Director of Kura Oncology, Inc. (KURA) and Director of Celularity Inc (CELU).
Signal8 holds 12 ownership filings by Parks Diane L., all Form 4s, filed between Dec 13, 2024 and Oct 13, 2026. Those filings report 16 transactions, from Dec 12, 2024 to Oct 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Parks Diane L.'s filings is in PRINCETON, NJ.
Recent filings by Parks Diane L.
- Oct 12, 2026: Disposition to issuer transactions of SNGX derivative securities (6 lines, Form 4, code D).
- Sep 17, 2026: Grant or award of SNGX derivative securities (Form 4, code A).
- Jun 4, 2026: Grant or award of KURA derivative securities (Form 4, code A).
- Jan 12, 2026: Grant or award of CELU shares (Form 4, code A).
- Dec 29, 2025: Grant or award of CELU shares (Form 4, code A).
Other insiders filing for SOLIGENIX, INC. (SNGX)
- ZELDIS JEROME B, Director
- RUBIN ROBERT J., Director
- LAPOINTE ANTHONY GREGG, Director
- Donini Oreola, CSO
- Guarino Jonathan L., CFO
- SCHABER CHRISTOPHER J, CHAIRMAN, CEO AND PRESIDENT